Heparanase promotes myeloma stemness and in vivo tumorigenesis
Open Access
- 5 December 2019
- journal article
- research article
- Published by Elsevier in Matrix Biology
- Vol. 88, 53-68
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA138340, CA211752, CA186646)
- United States – Israel Binational Science Foundation
- Leadiant Biosciences
This publication has 56 references indexed in Scilit:
- Undersulfation of Heparan Sulfate Restricts Differentiation Potential of Mouse Embryonic Stem CellsJournal of Biological Chemistry, 2012
- Heparan Sulfate Chains of Syndecan-1 Regulate Ectodomain SheddingJournal of Biological Chemistry, 2012
- SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 AxisClinical Cancer Research, 2011
- Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKLCancer Research, 2010
- Drosophila glypicans regulate the germline stem cell nicheJournal of Cell Biology, 2009
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in MyelomaJournal of Biological Chemistry, 2008
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug ResistanceCancer Research, 2008
- Heparanase: a target for drug discovery in cancer and inflammationBritish Journal of Pharmacology, 2007
- Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathyJournal of Experimental Medicine, 2007
- Hedgehog signaling maintains a tumor stem cell compartment in multiple myelomaProceedings of the National Academy of Sciences, 2007